1. 780: BENZODIAZEPINES AND TRANSITION TO DELIRIUM IN CRITICALLY ILL CHILDREN. Issue 12 (December 2016) Authors: Mody, Kalgi; Kaur, Savneet; Mauer, Elizabeth; Gerber, Linda; Greenwald, Bruce; Silver, Gabrielle; Traube, Chani Journal: Critical care medicine Issue: Volume 44:Issue 12(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 815: DOSE-RESPONSE RELATIONSHIP BETWEEN BENZODIAZEPINES AND DELIRIUM IN CRITICALLY ILL CHILDREN. (January 2018) Authors: Mody, Kalgi; Traube, Chani; Silver, Gabrielle; Greenwald, Bruce; Kaur, Savneet; Mauer, Elizabeth; Gerber, Linda Journal: Critical care medicine Issue: Volume 46:Supplement 1 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Benzodiazepines and Development of Delirium in Critically Ill Children: Estimating the Causal Effect*. Issue 9 (September 2018) Authors: Mody, Kalgi; Kaur, Savneet; Mauer, Elizabeth A.; Gerber, Linda M.; Greenwald, Bruce M.; Silver, Gabrielle; Traube, Chani Journal: Critical care medicine Issue: Volume 46:Issue 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study. Issue 6 (June 2022) Authors: Motzer, Robert; Porta, Camillo; Alekseev, Boris; Rha, Sun Young; Choueiri, Toni K; Mendez-Vidal, Maria Jose; Hong, Sung-Hoo; Kapoor, Anil; Goh, Jeffrey C; Eto, Masatoshi; Bennett, Lee; Wang, Jinyi; Pan, Jie Janice; Saretsky, Todd L; Perini, Rodolfo F; He, Cixin Steven; Mody, Kalgi; Cella, David Journal: Lancet oncology Issue: Volume 23:Issue 6(2022) Page Start: 768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale. (28th January 2019) Authors: Grünwald, Viktor; Powles, Thomas; Choueiri, Toni K; Hutson, Thomas E; Porta, Camillo; Eto, Masatoshi; Sternberg, Cora N; Rha, Sun Young; He, Cixin S; Dutcus, Corina E; Smith, Alan; Dutta, Lea; Mody, Kalgi; Motzer, Robert J Journal: Future oncology Issue: Volume 15:Number 9(2019) Page Start: 929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study. Issue 3 (March 2023) Authors: Choueiri, Toni K; Eto, Masatoshi; Motzer, Robert; De Giorgi, Ugo; Buchler, Tomas; Basappa, Naveen S; Méndez-Vidal, María José; Tjulandin, Sergei; Hoon Park, Se; Melichar, Bohuslav; Hutson, Thomas; Alemany, Carlos; McGregor, Bradley; Powles, Thomas; Grünwald, Viktor; Alekseev, Boris; Rha, Sun Youn... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial. (August 2021) Authors: Vogel, Arndt; Qin, Shukui; Kudo, Masatoshi; Su, Yun; Hudgens, Stacie; Yamashita, Tatsuya; Yoon, Jung-Hwan; Fartoux, Laetitia; Simon, Krzysztof; López, Carlos; Sung, Max; Mody, Kalgi; Ohtsuka, Tatsuroh; Tamai, Toshiyuki; Bennett, Lee; Meier, Genevieve; Breder, Valery Journal: Lancet gastroenterology and hepatology Issue: Volume 6:Number 8(2021) Page Start: 649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗